GlassScriptPhysician profile
Nathan Ezra Kramer
NPI 1891103925
$5,295.22
in general payments reported to CMS, 2019-2025
29 companies · $2,014 in 2025
The $2,014 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $63.49 · 2023: $1,454 · 2024: $1,764 · 2025: $2,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,231.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reapplix INC. | $547.20 | 2025 | 3c Patch Kit - Box |
| Ets Wound Care LLC | $510.60 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Abbott Laboratories | $508.41 | 2023-2025 | Diamondback Peripheral, Esprit |
| Kerecis Limited | $434.58 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Stryker Corporation | $419.69 | 2024-2025 | Ortholoc 3di, Claw II, Actishield |
| Depuy Synthes Sales INC. | $370.05 | 2023-2025 | N/A, Na, Motoband |
| Integra Lifesciences Corporation | $323.59 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $298.09 | 2023-2025 | Grafix Pl, Stravix Pl, Renasys Go V2 Home |
| Abbvie INC. | $258.95 | 2023-2025 | |
| Mimedx Group, INC. | $227.74 | 2024-2025 | |
| Medline Industries LP | $188.35 | 2023 | |
| Paratek Pharmaceuticals, INC. | $172.29 | 2024-2025 | Nuzyra |
| Heron Therapeutics, INC. | $145.51 | 2022-2023 | Zynrelef |
| Amgen INC. | $144.83 | 2024-2025 | Krystexxa |
| Next Science LLC | $142.99 | 2023-2025 | Xperience, Blastx, Surgx |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $116.49 | 2024 | V.A.C.Instill |
| Treace Medical Concepts, INC. | $94.36 | 2023-2025 | |
| Orthofix Medical, INC. | $84.49 | 2023-2025 | Physio-Stim |
| Bioventus LLC | $48.72 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Polynovo North America LLC | $45.52 | 2022-2025 | Novosorb Btm |
| Organogenesis INC. | $45.41 | 2025 | Affinity, Via Matrix |
| Acumed LLC | $31.63 | 2023 | Osteomed, Acumed |
| Lightbody Medical Technologies INC | $25.21 | 2025 | |
| Melinta Therapeutics, LLC | $22.49 | 2022 | |
| Sebela Pharmaceuticals INC. | $22.29 | 2023 | Pramosone, Naftin |
| Paragon 28, INC. | $19.63 | 2025 | Portfolio |
| Aroa Biosurgery Incorporated | $18.16 | 2023 | |
| Fusion Orthopedics USA, LLC | $14.39 | 2025 | |
| Linvatec Corporation | $13.56 | 2024 | Biobrace 23mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.